Neuramis Non-Lidocaine: A Professional Price Guide for Clinic Sourcing

Neuramis Non-Lidocaine is a hyaluronic acid (HA) dermal filler manufactured by Medytox, a South Korean pharmaceutical company. This specific variant is formulated without lidocaine, offering practitioners a choice for clients with sensitivities or specific treatment protocols. As a widely recognized Hyaluronic acid dermal filler catalog product, its availability and pricing structure are key considerations for clinics managing their inventory and treatment offerings. Sourcing strategies should focus on both cost efficiency and product authenticity.

The wholesale price for Neuramis Non-Lidocaine is influenced by supplier agreements and purchase volumes. To provide a clear reference point for professional buyers, we present an illustrative pricing model. This demonstrates how unit costs can vary based on the quantity acquired, directly impacting a clinic's operational economics.

For example, a baseline wholesale unit price could be set at $72.00, with discounts applied for larger orders. This model allows clinics to project their procurement costs accurately and plan inventory effectively.

Volume-based purchasing is a standard practice in the aesthetic wholesale market, designed to reward larger orders with reduced per-unit costs. These tiers significantly affect the potential profit margin for each treatment administered by your clinic.

Consider the following illustrative volume tier structure for Neuramis Non-Lidocaine:

This progressive discount system directly enhances a clinic's gross profit per syringe. For instance, moving from a 1-10 unit purchase to a 51+ unit purchase can decrease the unit cost by nearly 8%, representing a substantial saving that can be reinvested or contribute to increased profitability.

Clinic profitability hinges on a well-considered retail markup strategy. For hyaluronic acid fillers like Neuramis Non-Lidocaine, common professional markups range from 3x to 5x the wholesale cost per syringe. This accounts for professional fees, facility overhead, staff costs, and associated consumables.

As an example, if a single unit of Neuramis Non-Lidocaine is acquired at an illustrative wholesale cost of $69.12 (from the 11-20 unit tier), a 3.5x markup would suggest a client-facing price of approximately $241.92 per syringe-equivalent treatment. Understanding the initial wholesale price is crucial for setting competitive yet profitable client fees, balancing market demand with operational sustainability. Similar considerations apply when sourcing other popular fillers, such as detailed in our guide on Yvoire Classic Wholesale Price.

Efficient sourcing is not solely about securing the lowest price; it also involves reliability, consistency, and authenticity. For aesthetic clinics, bulk purchasing Neuramis Non-Lidocaine through established wholesale channels can lead to significant cost efficiencies, as demonstrated by the volume tiers. Planning inventory based on projected demand allows clinics to capitalize on these discounts.

Beyond Neuramis, diversifying your HA filler stock with products like Elasty Plus Non-Lido 2CC can cater to a broader client base and treatment needs. Regularly reviewing your procurement strategy ensures you are always optimizing for both cost and product availability. Our guide on Juvederm Wholesale: A Professional Sourcing Guide offers further insights into strategic purchasing for another key HA filler.